Febuxostat 80mg Tablets

Febuxostat 80mg is a urate-lowering medicine used for ongoing management of gout. It reduces the production of uric acid, helping limit the urate crystal deposits responsible for recurrent gout attacks and tophi.
Swallow with water at the same time each day, with or without food. Serum urate results guide dose adjustment. Continue established treatment through a gout flare unless a serious reaction occurs; a separate anti-inflammatory treatment may be needed for the flare.
Febuxostat inhibits xanthine oxidase, the enzyme involved in converting purines to uric acid. This lowers the supply of urate available to form crystals.
Nausea, diarrhoea, headache, rash and abnormal liver tests can occur. Gout attacks may initially become more frequent. Blistering rash, jaundice, chest pain or sudden weakness requires urgent care.
Do not combine febuxostat with azathioprine or mercaptopurine because severe toxicity can result. Tell your doctor about heart disease, stroke, liver or kidney impairment, pregnancy and breastfeeding. Liver tests and cardiovascular history are important before and during treatment.
Maintaining a lower urate level can gradually reduce crystal burden and future gout flares. It does not provide immediate pain relief during an acute attack.
Changes in urate levels can mobilise existing crystals and trigger early flares. Temporary flare-prevention treatment, often colchicine or an appropriate anti-inflammatory, may be included at the start.
Pain-free periods do not mean the urate problem has disappeared. Stopping ongoing treatment can allow uric acid to rise and crystal deposits to build up again.
No. Its role is to reduce urate production over time. Acute redness, swelling and severe joint pain need a separate flare-management treatment.
The starting dose and later changes depend on the urate response, kidney and liver function and treatment history. A higher strength is not automatically needed because a flare is more painful.
Clinical studies have raised cardiovascular safety concerns in people with established cardiovascular disease. Previous heart attack, stroke or angina helps determine the most appropriate urate-lowering treatment.
Hyperuricaemia: an elevated blood urate level; Tophi: deposits of urate crystals under the skin or around joints; Xanthine oxidase: an enzyme involved in uric-acid production; Gout flare: an episode of acute inflammation caused by urate crystals; AR: Febuxostat 80mg أقراص; FR: Febuxostat 80mg comprimés; PT: Febuxostat 80mg comprimidos; ES: Febuxostat 80mg comprimidos; RU: Febuxostat 80mg таблетки; ID: Febuxostat 80mg tablet; VI: Febuxostat 80mg viên nén; MS: Febuxostat 80mg tablet; TL: Febuxostat 80mg tableta; ZH-SG: Febuxostat 80mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Febuxostat 80mg Tablets under Gout Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Febuxostat 80mg Tablets